Patents Assigned to Infections Disease Research Institute
  • Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis
    Patent number: 8410258
    Abstract: Compositions and methods for preventing, treating and detecting leishmaniasis are disclosed. The compositions generally comprise fusion polypeptides comprising multiple Leishmania antigens, in particular, KMP11, SMT, A2 and/or CBP, or immunogenic portions or variants thereof, as well as polynucleotides encoding such fusion polypeptides.
    Type: Grant
    Filed: November 18, 2009
    Date of Patent: April 2, 2013
    Assignee: Infections Disease Research Institute
    Inventors: Yasuyuki Goto, Steven G. Reed